	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	01/05/2025
	www.isa.gov.il			www.tase.co.il				Reference:	2025-02-030694	Time of broadcast: 13:59 13:59

Immediate Report

Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on

_________

InterCure_Ltd_04_22_2025_Form_20_F_Filed_Version_isa.pdf


References of previous documents relating to this matter(the reference does not constitute incorporation by reference):



Stock Exchange/Market: -1	Date of revision of form structure: 06/08/2024
Address: Medinat ha-Yehudim Street 85 , Herzliya 4676670 Israel , Tel: 077-4605012 , Fax: 09-7680244
E-mail address: office@canndoc-pharma.com Company site: www.Intercure.co

Previous names of reporting entity:

Name of the Signatory: Kantor Ronen Position of Signatory in the reporting corporation: External Legal Counsel Name of Employer Company:
Address: BSR Tower 4, 33rd floor, Masada Street 7 , Bney Brak 5126112 Telephone: 03-6109100 Facsimile: 03-6133372 E-mail: rsoulema@dtkgg.com 1